Innate Pharma S.A. earnings per share and revenue

IPHA earnings per share for the last semiannual are -0.34 USD whereas the estimation was -0.30 USD which accounts for -13.99% surprise. Company revenue for the same period amounts to 13.63 M USD despite the estimated figure of 13.30 M USD. Estimated earnings per share for the next semiannual are -0.27 USD, and revenue is expected to reach 18.32 M USD. Also watch annual changes over time to get a bigger picture of IPHA earnings per share and revenue dynamics.